Jinfiniti Biosciences is a biomedical research and service firm focusing on biomarker and drug discoveries using high throughput (HTS) technologies. Jinfiniti provides research services to both biomedical research institutions and pharmaceutical companies with unique research reagents and services including nucleic acid isolation, molecular biology, monoclonal antibodies, immune assays, small compounds, HTS drug screening and data management/analysis. Jinfiniti is also engaged in developing biomarkers for human disease prediction, diagnosis and therapeutic monitoring as well as novel therapies for diabetes and cancer.  

Isolations Done to Date!